Articles | Volume 11, issue 3
https://doi.org/10.5194/jbji-11-257-2026
© Author(s) 2026. This work is distributed under
the Creative Commons Attribution 4.0 License.
the Creative Commons Attribution 4.0 License.
https://doi.org/10.5194/jbji-11-257-2026
© Author(s) 2026. This work is distributed under
the Creative Commons Attribution 4.0 License.
the Creative Commons Attribution 4.0 License.
CarboCell G/C provides sustained high local bone antibiotic levels with minimal systemic exposure, supporting its therapeutic potential in orthopedic infection management
Nicole Lind Henriksen
Department of Veterinary and Animal Sciences, University of Copenhagen, Copenhagen, Denmark
Department of Health Technology, Technical University of Denmark, Kgs. Lyngby, Denmark
Andrea René Jørgensen
Department of Orthopedic Surgery, Aarhus University, Aarhus, Denmark
Department of Clinical Medicine, Aarhus University, Aarhus N, Denmark
Michal Poborsky
Department of Plant and Environmental Sciences, University of Copenhagen, Denmark
Christoph Crocoll
Department of Plant and Environmental Sciences, University of Copenhagen, Denmark
Niranjan G. Kotla
Department of Health Technology, Technical University of Denmark, Kgs. Lyngby, Denmark
Catrine Jyde Berthelsen
Department of Health Technology, Technical University of Denmark, Kgs. Lyngby, Denmark
Department of Orthopedic Surgery, Aarhus University, Aarhus, Denmark
Department of Clinical Medicine, Aarhus University, Aarhus N, Denmark
Louise Kruse Jensen
Department of Veterinary and Animal Sciences, University of Copenhagen, Copenhagen, Denmark
Anders Elias Hansen
Department of Health Technology, Technical University of Denmark, Kgs. Lyngby, Denmark
Jonas Rosager Henriksen
CORRESPONDING AUTHOR
Department of Health Technology, Technical University of Denmark, Kgs. Lyngby, Denmark
Related authors
No articles found.
Josefine Slater, Maiken Stilling, Andreas Engel Krag, Sara Kousgaard Tøstesen, Mads Kristian Duborg Mikkelsen, Martin McNally, Alexander James Ramsden, Louise Kruse Jensen, Birgitte Jul Kiil, and Mats Bue
J. Bone Joint Infect., 10, 597–607, https://doi.org/10.5194/jbji-10-597-2025, https://doi.org/10.5194/jbji-10-597-2025, 2025
Short summary
Short summary
We developed a pig model to study how different tissue flaps support the healing microenvironment of lower-leg composite defects. By measuring tissue metabolism and examining tissue samples under the microscope, we found distinct early responses between muscle and fascia-based flaps. This model may help researchers and clinicians better understand the healing of complex bone and soft-tissue defects and may provide a platform for evaluating clinically relevant ortho-plastic outcomes.
Mads Kristian Duborg Mikkelsen, Andrea René Jørgensen, Niranjan G. Kotla, Maiken Stilling, Maria Bech Damsgaard, Christoph Crocoll, Michal Poborsky, Hans Christian Rasmussen, Jonas Rosager Henriksen, Anders Elias Hansen, and Mats Bue
J. Bone Joint Infect., 10, 327–334, https://doi.org/10.5194/jbji-10-327-2025, https://doi.org/10.5194/jbji-10-327-2025, 2025
Short summary
Short summary
In recent decades, there has been a growing emphasis on the use of local antibiotics in orthopaedic surgery, but development of new technologies has been limited. In this study we observe that a 1.5 mL injection of the novel technology CarboCell G/C into the bone provides very high levels of the antibiotics gentamicin and clindamycin in bones, with almost no spill to the bloodstream. These findings bolster the prospect of new and improved technologies for combatting orthopaedic infections.
Anton Alexander Nolte Peterlin, Louise Kruse Jensen, Emil Gleipner-Andersen, and Hans Gottlieb
J. Bone Joint Infect., 10, 199–206, https://doi.org/10.5194/jbji-10-199-2025, https://doi.org/10.5194/jbji-10-199-2025, 2025
Short summary
Short summary
Diabetic foot osteomyelitis is a severe diabetes complication that increases the risk of limb loss and death. This study assessed a one-stage surgical approach with primary wound closure and local antibiotics, showing favourable results. Among 97 patients, 13 needed further treatment, but only 4 required major amputation. Poor circulation was the main factor in failure. These findings challenge traditional methods and may improve quality of life, although further high-quality trials are needed.
Louise Kruse Jensen, Thomas Bjarnsholt, Hans Gottlieb, and Mats Bue
J. Bone Joint Infect., 10, 1–5, https://doi.org/10.5194/jbji-10-1-2025, https://doi.org/10.5194/jbji-10-1-2025, 2025
Short summary
Short summary
To improve the existing knowledge and treatment of bone and joint infections, it is essential to unite medical disciplines and bridge the gap between basic and clinical sciences. In 2018, the Centrum fOr translational Medicine on Bone and joint INfEctions (COMBINE) was created to facilitate collaboration among Danish scientists and researchers dedicated to bone and joint infection research. This paper aims to share the COMBINE approach and values.
Rehne Lessmann Hansen, Mats Bue, Anna Bertoli Borgognoni, and Klaus Kjær Petersen
J. Bone Joint Infect., 7, 35–42, https://doi.org/10.5194/jbji-7-35-2022, https://doi.org/10.5194/jbji-7-35-2022, 2022
Short summary
Short summary
This study consists of 26 patients with infection of the pubic symphysis. The authors believe that by drawing awareness to this condition patients may be diagnosed and undergo surgery faster; 21 of the patients had pelvic surgery before onset of pubic infection. The diagnostic delay was between 1 and 12 months. All patients underwent surgical debridement and received a minimum of 6 weeks antibiotic treatment; 23 patients had postoperative pain relief and 19 patients were ambulant without aids.
Cited articles
Azeredo, F. J., Dalla Costa, T., and Derendorf, H.: Role of microdialysis in pharmacokinetics and pharmacodynamics: current status and future directions. Clin. Pharmacokinet., 53, 205–212, https://doi.org/10.1007/s40262-014-0131-8, 2014.
Bezstarosti, H., Van Lieshout, E. M. M., Van Den Hurk, M. J. B., Kortram, K., Oprel, P., Koch, B. C. P., Croughs, P. D., and Verhofstad, M. H. J.: In vitro elution of gentamicin from CERAMENT® G has an antimicrobial effect on bacteria with various levels of gentamicin resistance found in fracture-related infection, Clin. Orthop. Relat. R., 482, 885–891, http://https://doi.org/10.1097/CORR.0000000000002975, 2024.
Blirup-Plum, S. A., Bjarnsholt, T., Jensen, H. E., Kragh, K. N., Aalbæk, B., Gottlieb, H., Bue, M., and Jensen, L. K.: Pathological and microbiological impact of a gentamicin-loaded biocomposite following limited or extensive debridement in a porcine model of osteomyelitis, Bone Joint Res., 9, 394–401, https://doi.org/10.1302/2046-3758.97.BJR-2020-0007.R1, 2020.
Colding-Rasmussen, T., Horstmann, P., Petersen, M. M., and Hettwer, W.: Antibiotic Elution Characteristics and Pharmacokinetics of Gentamicin and Vancomycin from a Mineral Antibiotic Carrier: An in vivo Evaluation of 32 Clinical Cases, J. Bone Joint Infect., 3, 234–240, https://doi.org/10.7150/jbji.26301, 2018.
Fink, B., Vogt, S., Reinsch, M., and Büchner, H.: Sufficient release of antibiotic by a spacer 6 weeks after implantation in two-stage revision of infected hip prostheses, Clin. Orthop. Relat. R., 469, 3141–3147, https://doi.org/10.1007/s11999-011-1937-4, 2011.
Fleiter, N., Walter, G., Bösebeck, H., Vogt, S., Büchner, H., Hirschberger, W., and Hoffman, A.: Clinical use and safety of a novel gentamicin-releasing resorbable bone graft substitute in the treatment of osteomyelitis/osteitis, Bone Joint Res., 3, 223–229, https://doi.org/10.1302/2046-3758.37.2000301, 2014.
Fuglsang-Madsen, A. J., Henriksen, N. L., Chávez, E. S., Kvich, L. A., Birch, J. K. M., Hartmann, K. T., Eriksen, T., Bjarnsholt, T., Gottlieb, H., Andresen, T. L., Jensen, L. K., Henriksen, J. R., and Hansen, A. E.: Eradication of Staphylococcus aureus in implant-associated osteomyelitis by an injectable in situ-forming depot antibiotics delivery system, J. Infect Dis., 230, 614–623, https://doi.org/10.1093/infdis/jiae139, 2024.
Henriksen, N. L., Serrano-Chávez, E., Fuglsang-Madsen, A., Jensen, L. K., Gottlieb, H., Bue, M., Andresen, T. L., Henriksen, J. R., and Hansen, A. E.: Gentamicin and clindamycin antibiotic-eluting depot technology eradicates S. aureus in an implant-associated osteomyelitis pig model without systemic antibiotics, Antimicrob. Agents Ch., 68, e00691-24, https://doi.org/10.1128/aac.00691-24, 2024.
Jennings, J. A., Abdelbary, H., Abdulla, F. S., Arafah, O., Benzouak, T., Choe, H., Coenye, T., Coraça-Huber, D. C., Drago, L., Gustavo Garcia, R., Goh, G. S., Hamilton, J., Hamoudeh, R., Hickok, N. J., Jensen, L. K., Lee, H. G., Li, B., Manzary, M., Markovics, A., McDonald, K., Fintan Moriarty, T., Muthukrishnan, G., Nishitani, K., Norton, N. J., Oral, E., Parvizi, J., Del Pozo, J., Priddy, L. B., Raafat, D., Saeed, K., Spiegel, C., Schwarz, E. M., Siverino, C., Trobos, M., Tubbs, A., and Yeasmin, R.: 2025 International Consensus Meeting on Musculoskeletal Infection: summary from biofilm workgroup on treatment of biofilm-related infection and preclinical models, J. Orthop. Res., 44, e70169, http://https://doi.org/10.1002/jor.70169, 2026.
Jørgensen, A. R., Hansen, J., Bue, M., Hanberg, P., and Stilling, M.: Microdialysis as a sampling tool for the chemotherapeutic agent doxorubicin, J. Pharm. Biomed. Anal., 239, 115872, https://doi.org/10.1016/j.jpba.2023.115872, 2024.
Klinder, A., Zaatreh, S., Ellenrieder, M., Redanz, S., Podbielski, A., Reichel, T., Bösebeck, H., Mittelmeier, W., and Bader, R.: Antibiotics release from cement spacers used for two-stage treatment of implant-associated infections after total joint arthroplasty, J. Biomed. Mater. Res. B., 107, 1587–1597, https://doi.org/10.1002/jbm.b.34251, 2019.
Lee, S. I., Lee, J. H., Park, S. Y., and Park, J. W.: Do bupivacaine, clindamycin, and gentamicin at their clinical concentrations enhance rocuronium-induced neuromuscular block?, Korean J. Anesthesiol., 64, 346, https://doi.org/10.4097/kjae.2013.64.4.346, 2013.
Martínez-Moreno, J., Merino, V., Nácher, A., Rodrigo, J. L., Climente, M., and Merino-Sanjuán, M.: Antibiotic-loaded bone cement as prophylaxis in total joint replacement, Orthop. Surg., 9, 331–341, https://doi.org/10.1111/os.12351, 2017.
Mikkelsen, M. K. D., Jørgensen, A. R., Kotla, N. G., Stilling, M., Damsgaard, M. B., Crocoll, C., Poborsky, M., Rasmussen, H. C., Henriksen, J. R., Hansen, A. E., and Bue, M.: CarboCell G/C offers high and prolonged concentrations of gentamicin and clindamycin in bone tissue following intraosseous injection, J. Bone Joint Infect., 10, 327–334, https://doi.org/10.5194/jbji-10-327-2025, 2025.
Minelli, E. B., Benini, A., Magnan, B., and Bartolozzi, P.: Release of gentamicin and vancomycin from temporary human hip spacers in two-stage revision of infected arthroplasty, J. Antimicrob. Chemoth., 53, 329–334, https://https://doi.org/10.1093/jac/dkh032, 2004.
Mouton, J. W., Theuretzbacher, U., Craig, W. A., Tulkens, P. M., Derendorf, H., and Cars, O.: Tissue concentrations: do we ever learn? J. Antimicrob. Chemoth., 61, 235–237, https://doi.org/10.1093/jac/dkm476, 2007.
Müller, M., Dela Peña, A., and Derendorf, H.: Issues in pharmacokinetics and pharmacodynamics of anti-infective agents: distribution in tissue, Antimicrob. Agents Ch., 48, 1441–1453, https://doi.org/10.1128/AAC.48.5.1441-1453.2004, 2004.
Olsen Kipp, J., Hanberg, P., Slater, J., Møller Nielsen, L., Storgaard Jakobsen, S., Stilling, M., and Bue, M.: Vancomycin bone and tissue concentrations following tibial intraosseous administration – evaluated in a porcine model, J. Bone Joint Infect., 6, 99–106, https://doi.org/10.5194/jbji-6-99-2021, 2021.
Pea, F.: Penetration of antibacterials into bone: what do we really need to know for optimal prophylaxis and treatment of bone and joint infections?, Clin. Pharmacokinet., 48, 125–127, https://doi.org/10.2165/00003088-200948020-00003, 2009.
Russo, M., Monnin, C., Zhang, Y. L., Montreuil, J., Tanzer, M., Avizonis, D., and Hart, A. A.: A novel method for quantification of cefazolin local tissue concentration in blood, fat, synovium, and bone marrow using liquid chromatography–mass spectrometry, J. Pharm. Biomed. Anal., 234, 115566, https://doi.org/10.1016/j.jpba.2023.115566, 2023.
Schwarz, E. M., McLaren, A. C., Sculco, T. P., Brause, B., Bostrom, M., and Kates, S. L.: Adjuvant antibiotic-loaded bone cement: concerns with current use and research to make it work, J. Orthop. Res., 39, 227–239, https://doi.org/10.1002/jor.24616, 2021.
Selby, N. M., Shaw, S., Woodier, N., Fluck, R. J., and Kolhe, N. V.: Gentamicin-associated acute kidney injury, QJM, 102, 873–880, https://doi.org/10.1093/qjmed/hcp143, 2009.
Steadman, W., Chapman, P. R., Schuetz, M., Schmutz, B., Trampuz, A., and Tetsworth, K.: Local antibiotic delivery options in prosthetic joint infection, Antibiotics, 12, 752, https://doi.org/10.3390/antibiotics12040752, 2023
Stolle, L. B.: Application of microdialysis to cancellous bone tissue for measurement of gentamicin levels, J. Antimicrob. Chemoth., 54, 263–265, https://doi.org/10.1093/jac/dkh291, 2004.
Vittrup, S., Jensen, L. K., Hartmann, K. T., Aalbæk, B., Hanberg, P., Slater, J., Hvistendahl, M. A., Stilling, M., Jørgensen, N. P., and Bue, M.: Rifampicin does not reduce moxifloxacin concentrations at the site of infection and may not improve treatment outcome of a one-stage exchange surgery protocol of implant-associated osteomyelitis lesions in a porcine model, APMIS, 132, apm.13371, https://doi.org/10.1111/apm.13371, 2023.
Zhao, Y., Prideaux, B., Baistrocchi, S., Sheppard, D. C., and Perlin, D. S.: Beyond tissue concentrations: antifungal penetration at the site of infection, Med. Mycol., 57, S161–S167, https://doi.org/10.1093/mmy/myy067, 2019.
Zimmerli, W. and Moser, C.: Pathogenesis and treatment concepts of orthopaedic biofilm infections, FEMS Immunol. Med. Mic., 65, 158–168, https://doi.org/10.1111/j.1574-695X.2012.00938.x, 2012.
Short summary
CarboCell is an injectable material designed to release antibiotics directly where bone infections occur. We tested it in animals and found that it delivered high and long-lasting drug levels in bone while keeping drug levels in the rest of the body very low. This suggests that CarboCell may improve infection treatment and reduce the need for whole-body antibiotic therapy.
CarboCell is an injectable material designed to release antibiotics directly where bone...